Finance

Lists
Q3 2026 earnings • in 1 day
See details
MLYS:NASDAQ
Mineralys Therapeutics Inc
၁၅.၅၅ US$
၀.၀၀%
(၀.၀၀) 1D
နို ၂, GMT-၅ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MLYS...
Mkt. cap
၁၃၇.၄၇ ဋေ
Avg. vol.
၁.၅၉ သန်း
Volume
၇.၅၀ ထောင်
52-wk high
၄၇.၆၅ US$
52-wk low
၁၈.၁၁ US$
EPS
-၄.၂၄ US$
Beta
၀.၈၃
Shares outstanding
၈.၈၄ ကုဋေ
No. of employees
၇၆
Mkt. cap
၁၃၇.၄၇ ဋေ
Avg. vol.
၁.၅၉ သန်း
Volume
၇.၅၀ ထောင်
52-wk high
၄၇.၆၅ US$
52-wk low
၁၈.၁၁ US$
EPS
-၄.၂၄ US$
Beta
၀.၈၃
Shares outstanding
၈.၈၄ ကုဋေ
No. of employees
၇၆
News stories
From web sources and news partners
MyChesCo
MyChesCo
·
ပြီးခဲ့သည့် ၈ မိနစ်
Mineralys Sets November 4 Earnings Call as Drug Trials Advance
About Mineralys Therapeutics Inc
CEO-
Employees၇၆
Founded၂၀၁၉
Headquarters-
Sector-
Websitemineralystx.com
Analyst ratings
Based on 7 analysts giving stock ratings to MLYS in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for MLYS in the last 3 months.
Highest
Current ၁၅.၅၅ US$
၅၆.၀၀ US$ (+၂၆၀.၁၃%)
Average
၄၇.၈၆ US$ (+၂၀၇.၇၈%)
Lowest
၂၉.၀၀ US$ (+၈၆.၅၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
၅၆.၀၀ US$
+၂၆၀.၁%
10/23/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
၄၉.၀၀ US$
+၂၁၅.၁%
10/12/2026
Unknown Analyst
UBS
Hold
Initiated
၂၉.၀၀ US$
+၈၆.၅%
10/11/2026
Alice Nettleton
UBS
Hold
Initiated
၂၉.၀၀ US$
+၈၆.၅%
10/11/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
၅၂.၀၀ US$
+၂၃၄.၄%
08/12/2026
Richard Law CFA
Goldman Sachs
Buy
Maintained
၄၀.၀၀ US$
+၁၅၇.၂%
08/12/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
၅၅.၀၀ US$
+၂၅၃.၇%
08/12/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
၅၅.၀၀ US$
+၂၅၃.၇%
08/12/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
၅၄.၀၀ US$
+၂၄၇.၃%
08/12/2026
Annabel Samimy
Stifel Nicolaus
Buy
Maintained
၅၂.၀၀ US$
+၂၃၄.၄%
05/07/2026
Unknown Analyst
Goldman Sachs
Buy
Reiterated
၄၂.၀၀ US$
+၁၇၀.၁%
05/07/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
05/06/2026
Next call in 31:14:14
နို ၄ ဗုဒ္ဓဟူး, ၂၃:၃၀
Fiscal period
Q3 2026
- / -၀.၅၄ US$
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၃.၁၄ ကုဋေ
၂.၄၄ ကုဋေ
၂.၄၄ ကုဋေ
၂၂.၁၄ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၉.၆၈ သန်း
၁.၃၉ ကုဋေ
၂.၁၀ ကုဋေ
၂.၄၇ ကုဋေ
Operating expense
၄.၁၁ ကုဋေ
၃.၈၃ ကုဋေ
၄.၅၃ ကုဋေ
၂၄.၆၀ ကုဋေ
Total operating expenses
၄.၁၁ ကုဋေ
၃.၈၃ ကုဋေ
၄.၅၃ ကုဋေ
၂၄.၆၀ ကုဋေ
Operating income
-၄.၁၁ ကုဋေ
-၃.၈၃ ကုဋေ
-၄.၅၃ ကုဋေ
-၂၄.၆၀ ကုဋေ
Other non operating income
၄.၀၀ ထောင်
၁.၀၀ ထောင်
၅.၀၀ ထောင်
၁.၃၀ သောင်း
EBT including unusual items
-၃.၆၉ ကုဋေ
-၃.၂၂ ကုဋေ
-၃.၉၃ ကုဋေ
-၂၄.၁၁ ကုဋေ
EBT excluding unusual items
-၃.၆၉ ကုဋေ
-၃.၂၂ ကုဋေ
-၃.၉၃ ကုဋေ
-၂၄.၁၁ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၃.၆၉ ကုဋေ
-၃.၂၂ ကုဋေ
-၃.၉၃ ကုဋေ
-၂၄.၁၁ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၅၂
-၀.၄၀
-၀.၄၇
-၂.၈၅
Interest and investment income
၄.၂၀ သန်း
၆.၀၄ သန်း
၆.၀၀ သန်း
၄.၉၆ သန်း
Interest expense
-
-
-
-
Net interest expenses
၄.၂၀ သန်း
၆.၀၄ သန်း
၆.၀၀ သန်း
၄.၉၆ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၄.၁၁ ကုဋေ
-၃.၈၃ ကုဋေ
-၄.၅၃ ကုဋေ
-၂၄.၆၀ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ